 | • レポートコード：QYR2104Z3789 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、脳幹前兆薬による片頭痛のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（中絶薬、予防薬）、用途別市場規模（小売薬局、病院薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脳幹前兆薬による片頭痛の市場動向 ・企業の競争状況、市場シェア ・脳幹前兆薬による片頭痛の種類別市場規模（中絶薬、予防薬） ・脳幹前兆薬による片頭痛の用途別市場規模（小売薬局、病院薬局、その他） ・脳幹前兆薬による片頭痛の北米市場規模2016-2027（アメリカ、カナダ） ・脳幹前兆薬による片頭痛のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳幹前兆薬による片頭痛のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳幹前兆薬による片頭痛の中南米市場規模2016-2027（メキシコ、ブラジル） ・脳幹前兆薬による片頭痛の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、GlaxoSmithKline、Abbott Laboratories、Eli Lily、Johnson & Johnson、AstraZeneca、Eisai、Allergen、Merck、Endo International、Impax Laboratories） ・結論 |
A migraine with brainstem aura is also known as a basilar migraine or basilar artery migraine. It is a rare type of a migraine that begins in the base of the brain (brain stem). A migraine with brainstem aura occurs in about 1.5% of the patients suffering from with a headache. This migraine can occur in men and women of all ages.
Geographically, the Americas is anticipated to dominate the global migraine with brainstem aura market owing to a well-developed healthcare sector, rising prevalence of migraine and growing healthcare expenditure.
Market Analysis and Insights: Global Migraine With Brainstem Aura Drugs Market
The global Migraine With Brainstem Aura Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Migraine With Brainstem Aura Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Migraine With Brainstem Aura Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Migraine With Brainstem Aura Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Migraine With Brainstem Aura Drugs market.
Global Migraine With Brainstem Aura Drugs Scope and Market Size
Migraine With Brainstem Aura Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Migraine With Brainstem Aura Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Abortive Medication
Preventive Medication
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
GlaxoSmithKline
Abbott Laboratories
Eli Lily
Johnson & Johnson
AstraZeneca
Eisai
Allergen
Merck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine With Brainstem Aura Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Abortive Medication
1.2.3 Preventive Medication
1.3 Market by Application
1.3.1 Global Migraine With Brainstem Aura Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Migraine With Brainstem Aura Drugs Market Perspective (2016-2027)
2.2 Migraine With Brainstem Aura Drugs Growth Trends by Regions
2.2.1 Migraine With Brainstem Aura Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Migraine With Brainstem Aura Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Migraine With Brainstem Aura Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Migraine With Brainstem Aura Drugs Industry Dynamic
2.3.1 Migraine With Brainstem Aura Drugs Market Trends
2.3.2 Migraine With Brainstem Aura Drugs Market Drivers
2.3.3 Migraine With Brainstem Aura Drugs Market Challenges
2.3.4 Migraine With Brainstem Aura Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Migraine With Brainstem Aura Drugs Players by Revenue
3.1.1 Global Top Migraine With Brainstem Aura Drugs Players by Revenue (2016-2021)
3.1.2 Global Migraine With Brainstem Aura Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Migraine With Brainstem Aura Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Migraine With Brainstem Aura Drugs Revenue
3.4 Global Migraine With Brainstem Aura Drugs Market Concentration Ratio
3.4.1 Global Migraine With Brainstem Aura Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine With Brainstem Aura Drugs Revenue in 2020
3.5 Migraine With Brainstem Aura Drugs Key Players Head office and Area Served
3.6 Key Players Migraine With Brainstem Aura Drugs Product Solution and Service
3.7 Date of Enter into Migraine With Brainstem Aura Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine With Brainstem Aura Drugs Breakdown Data by Type
4.1 Global Migraine With Brainstem Aura Drugs Historic Market Size by Type (2016-2021)
4.2 Global Migraine With Brainstem Aura Drugs Forecasted Market Size by Type (2022-2027)
5 Migraine With Brainstem Aura Drugs Breakdown Data by Application
5.1 Global Migraine With Brainstem Aura Drugs Historic Market Size by Application (2016-2021)
5.2 Global Migraine With Brainstem Aura Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Migraine With Brainstem Aura Drugs Market Size (2016-2027)
6.2 North America Migraine With Brainstem Aura Drugs Market Size by Type
6.2.1 North America Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021)
6.2.2 North America Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027)
6.2.3 North America Migraine With Brainstem Aura Drugs Market Size by Type (2016-2027)
6.3 North America Migraine With Brainstem Aura Drugs Market Size by Application
6.3.1 North America Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021)
6.3.2 North America Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027)
6.3.3 North America Migraine With Brainstem Aura Drugs Market Size by Application (2016-2027)
6.4 North America Migraine With Brainstem Aura Drugs Market Size by Country
6.4.1 North America Migraine With Brainstem Aura Drugs Market Size by Country (2016-2021)
6.4.2 North America Migraine With Brainstem Aura Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Migraine With Brainstem Aura Drugs Market Size (2016-2027)
7.2 Europe Migraine With Brainstem Aura Drugs Market Size by Type
7.2.1 Europe Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021)
7.2.2 Europe Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027)
7.2.3 Europe Migraine With Brainstem Aura Drugs Market Size by Type (2016-2027)
7.3 Europe Migraine With Brainstem Aura Drugs Market Size by Application
7.3.1 Europe Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021)
7.3.2 Europe Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027)
7.3.3 Europe Migraine With Brainstem Aura Drugs Market Size by Application (2016-2027)
7.4 Europe Migraine With Brainstem Aura Drugs Market Size by Country
7.4.1 Europe Migraine With Brainstem Aura Drugs Market Size by Country (2016-2021)
7.4.2 Europe Migraine With Brainstem Aura Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size (2016-2027)
8.2 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Type
8.2.1 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Application
8.3.1 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Region
8.4.1 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Migraine With Brainstem Aura Drugs Market Size (2016-2027)
9.2 Latin America Migraine With Brainstem Aura Drugs Market Size by Type
9.2.1 Latin America Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Migraine With Brainstem Aura Drugs Market Size by Type (2016-2027)
9.3 Latin America Migraine With Brainstem Aura Drugs Market Size by Application
9.3.1 Latin America Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Migraine With Brainstem Aura Drugs Market Size by Application (2016-2027)
9.4 Latin America Migraine With Brainstem Aura Drugs Market Size by Country
9.4.1 Latin America Migraine With Brainstem Aura Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Migraine With Brainstem Aura Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size (2016-2027)
10.2 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Type
10.2.1 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Application
10.3.1 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Country
10.4.1 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Migraine With Brainstem Aura Drugs Introduction
11.1.4 Pfizer Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Migraine With Brainstem Aura Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Migraine With Brainstem Aura Drugs Introduction
11.3.4 Abbott Laboratories Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 Eli Lily
11.4.1 Eli Lily Company Details
11.4.2 Eli Lily Business Overview
11.4.3 Eli Lily Migraine With Brainstem Aura Drugs Introduction
11.4.4 Eli Lily Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.4.5 Eli Lily Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Migraine With Brainstem Aura Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Migraine With Brainstem Aura Drugs Introduction
11.6.4 AstraZeneca Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Eisai
11.7.1 Eisai Company Details
11.7.2 Eisai Business Overview
11.7.3 Eisai Migraine With Brainstem Aura Drugs Introduction
11.7.4 Eisai Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.7.5 Eisai Recent Development
11.8 Allergen
11.8.1 Allergen Company Details
11.8.2 Allergen Business Overview
11.8.3 Allergen Migraine With Brainstem Aura Drugs Introduction
11.8.4 Allergen Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.8.5 Allergen Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Migraine With Brainstem Aura Drugs Introduction
11.9.4 Merck Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Endo International
11.10.1 Endo International Company Details
11.10.2 Endo International Business Overview
11.10.3 Endo International Migraine With Brainstem Aura Drugs Introduction
11.10.4 Endo International Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.10.5 Endo International Recent Development
11.11 Impax Laboratories
11.11.1 Impax Laboratories Company Details
11.11.2 Impax Laboratories Business Overview
11.11.3 Impax Laboratories Migraine With Brainstem Aura Drugs Introduction
11.11.4 Impax Laboratories Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021)
11.11.5 Impax Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Migraine With Brainstem Aura Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Abortive Medication
Table 3. Key Players of Preventive Medication
Table 4. Global Migraine With Brainstem Aura Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Migraine With Brainstem Aura Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Migraine With Brainstem Aura Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Migraine With Brainstem Aura Drugs Market Share by Regions (2016-2021)
Table 8. Global Migraine With Brainstem Aura Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Migraine With Brainstem Aura Drugs Market Share by Regions (2022-2027)
Table 10. Migraine With Brainstem Aura Drugs Market Trends
Table 11. Migraine With Brainstem Aura Drugs Market Drivers
Table 12. Migraine With Brainstem Aura Drugs Market Challenges
Table 13. Migraine With Brainstem Aura Drugs Market Restraints
Table 14. Global Migraine With Brainstem Aura Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Migraine With Brainstem Aura Drugs Market Share by Players (2016-2021)
Table 16. Global Top Migraine With Brainstem Aura Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine With Brainstem Aura Drugs as of 2020)
Table 17. Ranking of Global Top Migraine With Brainstem Aura Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Migraine With Brainstem Aura Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Migraine With Brainstem Aura Drugs Product Solution and Service
Table 21. Date of Enter into Migraine With Brainstem Aura Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Migraine With Brainstem Aura Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Migraine With Brainstem Aura Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Migraine With Brainstem Aura Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Migraine With Brainstem Aura Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Migraine With Brainstem Aura Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Migraine With Brainstem Aura Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Migraine With Brainstem Aura Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Migraine With Brainstem Aura Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Migraine With Brainstem Aura Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Migraine With Brainstem Aura Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Migraine With Brainstem Aura Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Migraine With Brainstem Aura Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Migraine With Brainstem Aura Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Migraine With Brainstem Aura Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Migraine With Brainstem Aura Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Migraine With Brainstem Aura Drugs Product
Table 64. Pfizer Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Migraine With Brainstem Aura Drugs Product
Table 69. GlaxoSmithKline Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Abbott Laboratories Company Details
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories Migraine With Brainstem Aura Drugs Product
Table 74. Abbott Laboratories Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 75. Abbott Laboratories Recent Development
Table 76. Eli Lily Company Details
Table 77. Eli Lily Business Overview
Table 78. Eli Lily Migraine With Brainstem Aura Drugs Product
Table 79. Eli Lily Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 80. Eli Lily Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Migraine With Brainstem Aura Drugs Product
Table 84. Johnson & Johnson Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Migraine With Brainstem Aura Drugs Product
Table 89. AstraZeneca Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. Eisai Company Details
Table 92. Eisai Business Overview
Table 93. Eisai Migraine With Brainstem Aura Drugs Product
Table 94. Eisai Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 95. Eisai Recent Development
Table 96. Allergen Company Details
Table 97. Allergen Business Overview
Table 98. Allergen Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 99. Allergen Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Migraine With Brainstem Aura Drugs Product
Table 103. Merck Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 104. Merck Recent Development
Table 105. Endo International Company Details
Table 106. Endo International Business Overview
Table 107. Endo International Migraine With Brainstem Aura Drugs Product
Table 108. Endo International Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 109. Endo International Recent Development
Table 110. Impax Laboratories Company Details
Table 111. Impax Laboratories Business Overview
Table 112. Impax Laboratories Migraine With Brainstem Aura Drugs Product
Table 113. Impax Laboratories Revenue in Migraine With Brainstem Aura Drugs Business (2016-2021) & (US$ Million)
Table 114. Impax Laboratories Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Migraine With Brainstem Aura Drugs Market Share by Type: 2020 VS 2027
Figure 2. Abortive Medication Features
Figure 3. Preventive Medication Features
Figure 4. Global Migraine With Brainstem Aura Drugs Market Share by Application: 2020 VS 2027
Figure 5. Retail Pharmacies Case Studies
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Others Case Studies
Figure 8. Migraine With Brainstem Aura Drugs Report Years Considered
Figure 9. Global Migraine With Brainstem Aura Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Migraine With Brainstem Aura Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Migraine With Brainstem Aura Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Migraine With Brainstem Aura Drugs Market Share by Regions (2022-2027)
Figure 13. Global Migraine With Brainstem Aura Drugs Market Share by Players in 2020
Figure 14. Global Top Migraine With Brainstem Aura Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine With Brainstem Aura Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Migraine With Brainstem Aura Drugs Revenue in 2020
Figure 16. Global Migraine With Brainstem Aura Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Migraine With Brainstem Aura Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Migraine With Brainstem Aura Drugs Market Share by Type (2016-2027)
Figure 20. North America Migraine With Brainstem Aura Drugs Market Share by Application (2016-2027)
Figure 21. North America Migraine With Brainstem Aura Drugs Market Share by Country (2016-2027)
Figure 22. United States Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Migraine With Brainstem Aura Drugs Market Share by Type (2016-2027)
Figure 26. Europe Migraine With Brainstem Aura Drugs Market Share by Application (2016-2027)
Figure 27. Europe Migraine With Brainstem Aura Drugs Market Share by Country (2016-2027)
Figure 28. Germany Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Migraine With Brainstem Aura Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Migraine With Brainstem Aura Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Migraine With Brainstem Aura Drugs Market Share by Region (2016-2027)
Figure 38. China Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Migraine With Brainstem Aura Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Migraine With Brainstem Aura Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Migraine With Brainstem Aura Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Migraine With Brainstem Aura Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Migraine With Brainstem Aura Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Migraine With Brainstem Aura Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Migraine With Brainstem Aura Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 59. Abbott Laboratories Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 60. Eli Lily Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 63. Eisai Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 64. Allergen Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 66. Endo International Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 67. Impax Laboratories Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の片頭痛治療薬市場規模・現状・予測（2021年-2027年） Migraine treatment usually is with over-the-counter (OTC) migraine medication or prescription drugs. Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes wi…- 世界の片頭痛市場規模・現状・予測（2021年-2027年） A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound,…
- 世界の片頭痛治療市場規模・現状・予測（2021年-2027年） Migraines are a family of recurrent attacks.The symptom is paroxysmal unilateral throbbing headache, accompanied by nausea, vomiting and confusion. Migraine therapeutics includes triptans, acetylcholine inhibitors/neurotoxins, ergot alkaloids, nsaids, ditan, CGRP small molecule antagonists, CGRP mon…
- 世界の片頭痛治療市場規模・現状・予測（2021年-2027年） Migraines are a family of recurrent attacks.The symptom is paroxysmal unilateral throbbing headache, accompanied by nausea, vomiting and confusion. Migraine therapeutics includes triptans, acetylcholine inhibitors/neurotoxins, ergot alkaloids, nsaids, ditan, CGRP small molecule antagonists, CGRP mon…
- 世界の市販鎮痛薬市場規模・現状・予測（2021年-2027年） Over-the-counter pain medication are very helpful for the person suffering from minor and major pain. As the over-the-counter are easily available without proper prescriptions and very effective to control the pain. Over-the-counter pain medication are approved product from the regulatory authority,…